Emerging frontiers in drug delivery with special focus on novel techniques for targeted therapies - 13/08/23
Abstract |
The management and treatment of disease are achieved via the use of pharmacologically active substances or drugs. Drugs do not, however, have an intrinsic ability to be effective; rather, how well they work depends on how they are administered or supplied. Treatment of a variety of biological illnesses, such as autoimmune disorders, cancer, and bacterial infections, requires effective drug delivery. Drug absorption, distribution, metabolism, duration of therapeutic impact, pharmacokinetics, excretion, and toxicity can all be impacted by drug administration. Improved chemistry and materials are required for the delivery of therapeutic concentration of novel treatments to the specified targets within the body, as well as for the necessary duration of time. This requirement is accompanied by the development of new therapeutics. Formulating a medication as a DDS is a promising strategy for directly addressing numerous typical barriers to adherence, such as frequent dosage, such as frequent dosage, side effects, and a delayed beginning of the action. In the current review, we give a compendium of drug delivery and controlled release and subsequently highlight some of the newest developments in the realm, with a particular emphasis on cutting-edge methods for targeted therapy. In each instance, we outline the obstacles to efficient drug administration as well as the chemical and material developments that are allowing the sector to overcome these obstacles and have a positive clinical impact.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Drug delivery systems (DDSs) can improve therapeutic efficacy of drugs with reduced side effects. |
• | Drug stability, release, and tissue/cell-specific targeting are challenging to anticipate. |
• | Injectable materials localize the drug to the site of action, reducing off-target toxicity and improving clinical impact. |
• | Intratumoral implantation reduced off-target effects and maximize therapeutic benefit. |
• | Systemic RNA treats genetic disease by finding abnormal body regions and restoring their essential functions. |
Keywords : Drug delivery systems, Controlled release, Systemic RNA delivery, Localized drug delivery, Oral delivery of biologics
Plan
Vol 165
Article 115049- septembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?